Our Vision
Our Mission To Make MRI and PET Imaging More Accessible More Cost Effective More Diagnostically Powerful
Our vision is to maximize MRI and PET image quality and redefine its capabilities, striving to create a non-invasive diagnostic tool for assessing the cellular microenvironment. Through innovations that refine image acquisition and processing, we are pushing the boundaries of medical diagnostics. Our commitment lies in enhancing the depth and nuance of MRI capabilities, ushering in a new era of diagnostic accuracy that empowers healthcare professionals with a more comprehensive view of the human body, leading to earlier and more precise interventions.
MICSI’s first product, MICSI-RMT, is FDA 510(k) cleared for MRI image quality enhancement. MICSI-PET, our second product, applies the same physics-based enhancement approach to PET imaging — enabling anatomically precise, higher-resolution amyloid and Tau PET on existing scanners. MICSI-PET FDA 510(k) submission is complete.
